
Sign up to save your podcasts
Or
Large scale covid-19 vaccine trials have taken place at exceptional speed with unprecedented scrutiny. How do they work? And why are the results so politically charged?
We speak to Andrew Catchpole, lead scientist on the first trial to infect volunteers with the virus intentionally. Jason Palmer, presenter of The Intelligence, assists in a trial.
Alok Jha, The Economist's science correspondent, hosts with our health policy editor, Natasha Loder. Slavea Chankova, The Economist's health-care correspondent, and James Fransham, from our data team, join them.
For full access to The Economist’s print, digital and audio editions subscribe at economist.com/thejabpod. Sign up for our new weekly science newsletter at economist.com/simplyscience and data newsletter at economist.com/offthecharts
Hosted on Acast. See acast.com/privacy for more information.
4.7
115115 ratings
Large scale covid-19 vaccine trials have taken place at exceptional speed with unprecedented scrutiny. How do they work? And why are the results so politically charged?
We speak to Andrew Catchpole, lead scientist on the first trial to infect volunteers with the virus intentionally. Jason Palmer, presenter of The Intelligence, assists in a trial.
Alok Jha, The Economist's science correspondent, hosts with our health policy editor, Natasha Loder. Slavea Chankova, The Economist's health-care correspondent, and James Fransham, from our data team, join them.
For full access to The Economist’s print, digital and audio editions subscribe at economist.com/thejabpod. Sign up for our new weekly science newsletter at economist.com/simplyscience and data newsletter at economist.com/offthecharts
Hosted on Acast. See acast.com/privacy for more information.
4,262 Listeners
926 Listeners
576 Listeners
110 Listeners
2,526 Listeners
1,083 Listeners
1,393 Listeners
101 Listeners
36 Listeners
881 Listeners
350 Listeners
505 Listeners
64 Listeners
66 Listeners
97 Listeners